The Chemours Company (CC) | Rumor.io

The Chemours

Attention (50-day avg)0%

Attention rank (50-day avg)#1,801

Bullish sentiment (50-day avg)48%

Price to earnings ratio67.8

Market capitalization2.1B

Earnings per share-2.02

Dividend yield (TTM)2.49%

Revenue (annual)5.8B

Net income (annual)-386M

Social

What share of all stock conversation is about CC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% +0	0% +0	0% +0

May 12

The Chemours Company's stock price is roughly $88 per share, with some context provided about a related stock, Canton Strategic.
A $10B IPO for Digital Asset could be bullish, but the size of the company is not the only question for The Chemours Company.
Canton Coin ($CC) has been integrated on its native chain and is available in-app, with an ETF launched in a 40-act fund.

Generated by AI

Sentiment

Of the messages about CC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	0% -100	76.88% +9.68
Bearish	—	—	100% new	23.12% -9.68

Bullish· Jul 10

The Chemours Company ($CC) has broken through a significant technical barrier at $14, indicating a strong upward momentum.
$CC has shown a double bottom pattern, forming on long-term support, which could lead to a potential breakout above its trend.
A significant volume increase is expected if $CC breaks above $15, which could lead to a good month for the stock.

Bearish· Feb 29

Chemours $CC's CEO and CFO have been put on leave, and the company's controller is also on administrative leave, amid a review of potential "material weaknesses" in its financial reporting.
The company's top executives have been placed on leave after Chemours announced disappointing preliminary FY23 results and delayed the filing of its 10-K, causing a significant stock price drop.
Chemours $CC's shares have plummeted 43% after the company's disappointing earnings and the departure of its top executives, raising concerns about the company's ability to survive with its huge debt.

Generated by AI

Topics

Of the messages about CC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	7.63%	29.32%
Technical Analysis	—	—	92.37%	59.9%
Analysts	—	—	0%	2.35%
Controversies	—	—	0%	0.2%
Earnings	—	—	0%	0.63%
Macro	—	—	0%	7.6%

Mar 1

The Chemours Company (CC) has delayed its earnings report due to internal review of financial reporting weaknesses, which may result in a net loss for the year.
Chemours' stock price has fallen due to potential financial reporting issues, with the company's CEO, CFO, and Principal Accounting Officer on leave amid an internal review.
Chemours has hosted its seventh annual Magical Science Camp for kids in China, promoting science education and community engagement.

Generated by AI

Community

Of the messages about CC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	18.85%
Newcomers	100%	100%	100%	81.15%

Regulars· Aug 19

Regular investors are actively buying CC, with multiple purchases of $35.05 at various prices, indicating a strong interest in the asset.
The LEAF report and AI swing trading prediction suggest a bullish outlook for CC, with the report possibly indicating a strong earnings season or favorable market conditions.
The mention of needing more tickers to check their app implies that the regulars are focused on providing information and insights to their followers, rather than simply promoting the app itself.

Newcomers· Feb 19

The newcomer is excited about the availability of $CC in the iTrust IRA, indicating it's a viable investment option.
The newcomer is focused on the upcoming catalysts for $CC, specifically the potential sale of the biotech business and the clarification of $CC's ownership stake.
The newcomer is taking a bullish position on $CC, expecting it to break through the $23.50 resistance level and is monitoring the stock's price movement closely.

Generated by AI

News

Are Options Traders Betting on a Big Move in Chemours Stock?

Investors need to pay close attention to CC stock based on the movements in the options market lately.

21h agouk.finance.yahoo.com

Did Chemours' (CC) US$455 Million PFAS Deal Just Reframe Its Long‑Term Liability Narrative?

On September 9, 2026, Chemours, DuPont, and Corteva reached a settlement with North Carolina and 11 nearby local entities, agreeing to pay US$455 million over 15 years to resolve PFAS-related claims tied to Chemours’ Fayetteville Works facility and other contamination issues. The agreement not only clears a significant portion of Chemours’ legacy PFAS exposure but also introduces a shared, net-present-value framework under the companies’ existing US$4.00 billion cost-sharing cap, potentially...

13d agoYahoo Finance

Chemours (CC) Trims Losses While Core Demand Keeps Slipping

On August 4, The Chemours Company (NYSE:CC) reported second-quarter results that read like two different companies fused. Net sales barely moved, adjusted profit shrank, and yet cash generation surged, and the loss on the bottom line narrowed sharply. For a stock trading under $40, that split personality is exactly what makes this quarter worth a […]

14d agoYahoo Finance

Analysts Are Bullish on These Materials Stocks: CRH plc (CRH), Chemours Company (CC)

Detailed price information for CRH Plc ADR (CRH-N) from The Globe and Mail including charting and trades.

17d agoThe Globe and Mail

Why Is Chemours Stock Trading Higher Today?

The Chemours Company (NYSE:CC) shares traded higher Thursday after the company, DuPont, and Corteva reached a $455 million settlement resolving PFAS-related litigation in North Carolina. The gain came despite broader weakness, with the S&P 500 down 0.43% and the Materials sector falling 1.24%. Chemours’ Share Covered By Existing Accruals Chemours, DuPont de Nemours, Inc. (NYSE:DD), and Corteva, Inc. (NYSE:CTVA) reached a $455 million settlement with North Carolina and 11 local entities over PFAS

19d agoYahoo Finance Singapore

Why is Chemours stock surging today?

19d agoInvesting.com

Also Discussed

Investors talking about CC also mention

#	Name	Attention
1	DuPont de Nemours, Inc.DD	0%new
2	Tronox Holdings plcTROX	0%new
3	Kronos Worldwide, Inc.KRO	0%new
4	CantonCC	0%-0.01
5	Tharimmune Inc.THAR	0%new
6	Trane Technologies plcTT	0%new
7	Latham Group, Inc.SWIM	0%new
8	Cerberus Cyber Sentinel CorporationCISO	0%0
9	Globe Life Inc.GL	0%new
10	Brookfield Business Corporation Class A Subordinate Voting SharesBBUC	0%-0.01

The Chemours Company

Basic Materials
Specialty Chemicals

The Chemours Company is a global chemistry company that develops and supplies industrial and specialty chemical products for a wide range of end markets. Its core business is organized into Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, each serving distinct applications across refrigeration and air conditioning, coatings, plastics, transportation, semiconductors, electronics, and general industrial uses. The company’s product portfolio includes refrigerants, thermal management solutions, propellants, blowing agents, specialty solvents, titanium dioxide pigments, and advanced fluoropolymer materials. These materials are used as key inputs in manufacturing and performance-driven applications, supporting customers that need durability, efficiency, brightness, opacity, and thermal control. Chemours serves a global customer base across North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, making it an important supplier within the specialty chemicals market.

Website

Location

1007 Market Street

Wilmington, DE, 19801

United States

Social

What share of all stock conversation is about CC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% +0	0% +0	0% +0

May 12

The Chemours Company's stock price is roughly $88 per share, with some context provided about a related stock, Canton Strategic.
A $10B IPO for Digital Asset could be bullish, but the size of the company is not the only question for The Chemours Company.
Canton Coin ($CC) has been integrated on its native chain and is available in-app, with an ETF launched in a 40-act fund.

Generated by AI

Sentiment

Of the messages about CC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	0% -100	76.88% +9.68
Bearish	—	—	100% new	23.12% -9.68

Bullish· Jul 10

The Chemours Company ($CC) has broken through a significant technical barrier at $14, indicating a strong upward momentum.
$CC has shown a double bottom pattern, forming on long-term support, which could lead to a potential breakout above its trend.
A significant volume increase is expected if $CC breaks above $15, which could lead to a good month for the stock.

Bearish· Feb 29

Chemours $CC's CEO and CFO have been put on leave, and the company's controller is also on administrative leave, amid a review of potential "material weaknesses" in its financial reporting.
The company's top executives have been placed on leave after Chemours announced disappointing preliminary FY23 results and delayed the filing of its 10-K, causing a significant stock price drop.
Chemours $CC's shares have plummeted 43% after the company's disappointing earnings and the departure of its top executives, raising concerns about the company's ability to survive with its huge debt.

Generated by AI

Topics

Of the messages about CC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	7.63%	29.32%
Technical Analysis	—	—	92.37%	59.9%
Analysts	—	—	0%	2.35%
Controversies	—	—	0%	0.2%
Earnings	—	—	0%	0.63%
Macro	—	—	0%	7.6%

Mar 1

The Chemours Company (CC) has delayed its earnings report due to internal review of financial reporting weaknesses, which may result in a net loss for the year.
Chemours' stock price has fallen due to potential financial reporting issues, with the company's CEO, CFO, and Principal Accounting Officer on leave amid an internal review.
Chemours has hosted its seventh annual Magical Science Camp for kids in China, promoting science education and community engagement.

Generated by AI

Community

Of the messages about CC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	18.85%
Newcomers	100%	100%	100%	81.15%

Regulars· Aug 19

Regular investors are actively buying CC, with multiple purchases of $35.05 at various prices, indicating a strong interest in the asset.
The LEAF report and AI swing trading prediction suggest a bullish outlook for CC, with the report possibly indicating a strong earnings season or favorable market conditions.
The mention of needing more tickers to check their app implies that the regulars are focused on providing information and insights to their followers, rather than simply promoting the app itself.

Newcomers· Feb 19

The newcomer is excited about the availability of $CC in the iTrust IRA, indicating it's a viable investment option.
The newcomer is focused on the upcoming catalysts for $CC, specifically the potential sale of the biotech business and the clarification of $CC's ownership stake.
The newcomer is taking a bullish position on $CC, expecting it to break through the $23.50 resistance level and is monitoring the stock's price movement closely.

Generated by AI

The Chemours

Social

May 12

Bullish· Jul 10

Bearish· Feb 29

Mar 1

Regulars· Aug 19

Newcomers· Feb 19

Are Options Traders Betting on a Big Move in Chemours Stock?

Did Chemours' (CC) US$455 Million PFAS Deal Just Reframe Its Long‑Term Liability Narrative?

Chemours (CC) Trims Losses While Core Demand Keeps Slipping

Analysts Are Bullish on These Materials Stocks: CRH plc (CRH), Chemours Company (CC)

Why Is Chemours Stock Trading Higher Today?

Why is Chemours stock surging today?

Also Discussed

The Chemours Company

Company Information

Location

Are Options Traders Betting on a Big Move in Chemours Stock?

Did Chemours' (CC) US$455 Million PFAS Deal Just Reframe Its Long‑Term Liability Narrative?

Chemours (CC) Trims Losses While Core Demand Keeps Slipping

Analysts Are Bullish on These Materials Stocks: CRH plc (CRH), Chemours Company (CC)

Why Is Chemours Stock Trading Higher Today?

Why is Chemours stock surging today?

Also Discussed

Social

May 12

Bullish· Jul 10

Bearish· Feb 29

Mar 1

Regulars· Aug 19

Newcomers· Feb 19